Due to shared physiological characteristics and rates of comorbidity among adenomyosis and endometrial cancer, we set out to further explore the role of RPLP1 in the pathogenesis of adenomyosis and endometrial cancer by assessing its expression in human tissues and cell lines as well as assessing its ability to regulate cell viability and migration in vitro. Here, RPLP1 is linked to adenomyosis.